Cargando…

Exploring the Burden of Mealtime Insulin Dosing in Adults and Children With Type 1 Diabetes

Timely and accurate mealtime insulin dosing can be an ongoing challenge for people with type 1 diabetes. This multinational, online study aimed to explore attitudes and behaviors around mealtime insulin dosing and the impact of mealtime dose timing, particularly with regard to premeal dosing (15–20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lane, Wendy, Lambert, Emma, George, Jesso, Rathor, Naveen, Thalange, Nandu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2021
Materias:	Feature Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603317/ https://www.ncbi.nlm.nih.gov/pubmed/34866778 http://dx.doi.org/10.2337/cd20-0117

Ejemplares similares

Abstract 21: The burden of mealtime insulin dosing in adults and children with type 1 diabetes
por: Revanna, Manjunatha, et al.
Publicado: (2022)

The Burden and Impacts of Mealtime Insulin from the Perspective of People with Diabetes
por: Paczkowski, R., et al.
Publicado: (2023)

Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK
por: Thalange, Nandu, et al.
Publicado: (2019)

Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2–16 Years
por: Thalange, Nandu, et al.
Publicado: (2016)

Improving the Estimation of Mealtime Insulin Dose in Adults With Type 1 Diabetes: The Normal Insulin Demand for Dose Adjustment (NIDDA) study
por: Bao, Jiansong, et al.
Publicado: (2011)

Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes
por: Thalange, Nandu, et al.
Publicado: (2015)

Clinical Use of Degludec in Children and Adolescents with T1D: A Narrative Review with Fictionalized Case Reports
por: Thalange, Nandu, et al.
Publicado: (2019)

The rate of hyperglycemia and ketosis with insulin degludec‐based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials
por: Thalange, Nandu, et al.
Publicado: (2019)

An exploration of eating behaviours and caregiver mealtime actions of children with Tourette syndrome
por: Smith, Bobbie L., et al.
Publicado: (2022)

‘After mealtime is before mealtime’ – an ethnographic exploration of nursing home residents’ practices of dealing with meal requirements
por: Stöhr, Doreen, et al.
Publicado: (2022)

Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study
por: Lane, Wendy, et al.
Publicado: (2021)

Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin
por: Evans, Marc, et al.
Publicado: (2019)

Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes
por: Riddle, Matthew, et al.
Publicado: (2009)

Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing
por: Cui, Ling, et al.
Publicado: (2020)

Family mealtime emotions and food parenting practices among mothers of young children: Development of the Mealtime Emotions Measure for Parents (MEM‐P)
por: White, Hannah J., et al.
Publicado: (2022)

Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch
por: Peyrot, Mark, et al.
Publicado: (2018)

Comparison of Insulin Dose Adjustments by Primary Care Physicians and Endocrinologists
por: Davidson, Mayer B., et al.
Publicado: (2018)

Early History, Mealtime Environment, and Parental Views on Mealtime and Eating Behaviors among Children with ASD in Florida
por: Gray, Heewon L., et al.
Publicado: (2018)

Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin
por: Warren, Mark L., et al.
Publicado: (2017)

Mealtime media use and cardiometabolic risk in children
por: Jamnik, Joseph, et al.
Publicado: (2022)

Mealtime insulin BOLUS score increases prior to clinic visits in youth with type 1 diabetes
por: McConville, Andrew, et al.
Publicado: (2020)

Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care
por: Brunton, Stephen A., et al.
Publicado: (2016)

Math and Data Exploration
por: Liu, Dennis
Publicado: (2010)

Update on Insulin Therapy for Type 2 Diabetes
por: Donner, Thomas, et al.
Publicado: (2012)

Decreasing the Nursing Documentation Burden During the Covid-19 Surge
por: Holub, Marci, et al.
Publicado: (2023)

A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9)
por: Lane, Wendy S., et al.
Publicado: (2020)

Life Sciences Career Exploration
por: Stark, Louisa A.
Publicado: (2011)

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
por: Pscherer, Stefan, et al.
Publicado: (2010)

Mealtime fast‐acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin‐resistant Type 2 diabetes
por: Bowering, K., et al.
Publicado: (2018)

Insulin Initiation and Titration in Patients With Type 2 Diabetes
por: Chun, Ji, et al.
Publicado: (2019)

Alcohol’s Burden on Immunity Following Burn, Hemorrhagic Shock, or Traumatic Brain Injury
por: Molina, Patricia E., et al.
Publicado: (2015)

Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy
por: Matza, Louis S., et al.
Publicado: (2019)

A Golden Age of Brain Exploration
por: Gewin, Virginia
Publicado: (2005)

Advances in Insulin Therapy: A Review of New Insulin Glargine 300 Units/mL in the Management of Diabetes
por: White, John R.
Publicado: (2016)

Pycnodysostosis: A Growth Hormone Responsive Skeletal Dysplasia
por: Omer Sulaiman, Hafsa, et al.
Publicado: (2021)

Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial
por: Thalange, N, et al.
Publicado: (2013)

Real-world efficacy and safety of insulin degludec with mealtime rapid-acting insulin in type 1 diabetes in Indian pediatric population
por: Kochar, Inderpal Singh, et al.
Publicado: (2018)

Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
por: Heller, Simon, et al.
Publicado: (2023)

The association between anti‐insulin aspart antibodies and the pharmacokinetic and pharmacodynamic characteristics of fast‐acting insulin aspart in children and adolescents with type 1 diabetes
por: Biester, Torben, et al.
Publicado: (2020)

Daily injection of melatonin inhibits insulin resistance induced by chronic mealtime shift
por: Park, Jihyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s51u8e0ok8fv0dgu5vv4inie94